Q3 2017 Earnings Forecast for Zimmer Biomet Holdings, Inc. (ZBH) Issued By Leerink Swann

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) – Research analysts at Leerink Swann reduced their Q3 2017 EPS estimates for Zimmer Biomet Holdings in a report issued on Thursday. Leerink Swann analyst R. Newitter now anticipates that the medical equipment provider will earn $1.72 per share for the quarter, down from their prior estimate of $1.76. Leerink Swann currently has a “Outperform” rating and a $146.00 target price on the stock. Leerink Swann also issued estimates for Zimmer Biomet Holdings’ FY2017 earnings at $8.21 EPS, FY2018 earnings at $8.63 EPS and FY2019 earnings at $9.54 EPS.

A number of other analysts have also recently weighed in on ZBH. Oppenheimer Holdings, Inc. set a $137.00 price target on shares of Zimmer Biomet Holdings and gave the company a “buy” rating in a research report on Monday, August 14th. BidaskClub downgraded shares of Zimmer Biomet Holdings from a “hold” rating to a “sell” rating in a research report on Tuesday, August 1st. SunTrust Banks, Inc. restated a “buy” rating and issued a $136.00 price target on shares of Zimmer Biomet Holdings in a research report on Monday, October 2nd. Canaccord Genuity restated a “buy” rating and issued a $141.00 price target on shares of Zimmer Biomet Holdings in a research report on Friday, July 14th. Finally, BMO Capital Markets upped their price target on shares of Zimmer Biomet Holdings from $136.00 to $140.00 and gave the company an “outperform” rating in a research report on Friday, July 28th. Three investment analysts have rated the stock with a sell rating, eight have assigned a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $136.55.

COPYRIGHT VIOLATION NOTICE: “Q3 2017 Earnings Forecast for Zimmer Biomet Holdings, Inc. (ZBH) Issued By Leerink Swann” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this report on another website, it was copied illegally and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this report can be accessed at https://www.dispatchtribunal.com/2017/10/14/q3-2017-earnings-forecast-for-zimmer-biomet-holdings-inc-zbh-issued-by-leerink-swann.html.

Shares of Zimmer Biomet Holdings (ZBH) opened at 119.70 on Friday. The firm’s 50-day moving average price is $115.99 and its 200-day moving average price is $120.39. Zimmer Biomet Holdings has a 12 month low of $95.63 and a 12 month high of $133.49. The company has a market capitalization of $24.20 billion, a price-to-earnings ratio of 34.09 and a beta of 1.19.

Zimmer Biomet Holdings (NYSE:ZBH) last announced its earnings results on Thursday, July 27th. The medical equipment provider reported $2.08 EPS for the quarter, missing the Zacks’ consensus estimate of $2.10 by ($0.02). Zimmer Biomet Holdings had a return on equity of 16.70% and a net margin of 9.12%. The company had revenue of $1.95 billion during the quarter, compared to analysts’ expectations of $1.95 billion. During the same quarter last year, the firm posted $2.02 EPS. Zimmer Biomet Holdings’s revenue for the quarter was up 1.1% compared to the same quarter last year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, September 22nd will be issued a dividend of $0.24 per share. The ex-dividend date is Thursday, September 21st. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.80%. Zimmer Biomet Holdings’s dividend payout ratio is currently 27.59%.

In other Zimmer Biomet Holdings news, VP Tony W. Collins sold 16,986 shares of the firm’s stock in a transaction on Monday, July 31st. The shares were sold at an average price of $121.74, for a total value of $2,067,875.64. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Company insiders own 1.07% of the company’s stock.

A number of hedge funds and other institutional investors have recently bought and sold shares of ZBH. Enterprise Financial Services Corp boosted its position in shares of Zimmer Biomet Holdings by 0.3% during the 2nd quarter. Enterprise Financial Services Corp now owns 2,646 shares of the medical equipment provider’s stock valued at $340,000 after acquiring an additional 9 shares in the last quarter. Sandy Spring Bank boosted its position in shares of Zimmer Biomet Holdings by 1.7% during the 1st quarter. Sandy Spring Bank now owns 1,222 shares of the medical equipment provider’s stock valued at $149,000 after acquiring an additional 20 shares in the last quarter. Cleararc Capital Inc. boosted its position in shares of Zimmer Biomet Holdings by 0.5% during the 1st quarter. Cleararc Capital Inc. now owns 4,897 shares of the medical equipment provider’s stock valued at $598,000 after acquiring an additional 25 shares in the last quarter. Parkside Financial Bank & Trust boosted its position in shares of Zimmer Biomet Holdings by 3.9% during the 2nd quarter. Parkside Financial Bank & Trust now owns 872 shares of the medical equipment provider’s stock valued at $112,000 after acquiring an additional 33 shares in the last quarter. Finally, CWA Asset Management Group LLC boosted its position in shares of Zimmer Biomet Holdings by 1.8% during the 2nd quarter. CWA Asset Management Group LLC now owns 1,952 shares of the medical equipment provider’s stock valued at $251,000 after acquiring an additional 34 shares in the last quarter. Institutional investors own 85.36% of the company’s stock.

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Earnings History and Estimates for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply